|
|
Volumn 30, Issue 3, 2012, Pages 199-200
|
|
Companies in rapid pursuit of Btk immunokinase
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AVL 292;
BENDAMUSTINE;
BRUTON TYROSINE KINASE;
BRUTON TYROSINE KINASE INHIBITOR;
CYCLOPHOSPHAMIDE;
DOXORUBICIN;
ENZYME INHIBITOR;
FLUDARABINE;
ONO WG 37;
PCI 32765;
PREDNISONE;
RITUXIMAB;
UNCLASSIFIED DRUG;
VINCRISTINE;
B CELL LYMPHOMA;
CHRONIC LYMPHATIC LEUKEMIA;
DRUG EFFECT;
DRUG EFFICACY;
DRUG MECHANISM;
DRUG MEGADOSE;
DRUG RESEARCH;
DRUG TARGETING;
ENZYME ACTIVITY;
HUMAN;
LARGE CELL LYMPHOMA;
LOW DRUG DOSE;
LYMPHOCYTOMA;
MANTLE CELL LYMPHOMA;
MULTIPLE MYELOMA;
NONHODGKIN LYMPHOMA;
NOTE;
PRIORITY JOURNAL;
WALDENSTROEM MACROGLOBULINEMIA;
B-LYMPHOCYTES;
DRUG INDUSTRY;
HUMANS;
LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL;
LYMPHOMA, NON-HODGKIN;
PROTEIN KINASE INHIBITORS;
PROTEIN-TYROSINE KINASES;
|
|
EID: 84857975111
PISSN: 10870156
EISSN: 15461696
Source Type: Journal
DOI: 10.1038/nbt0312-199 Document Type: Note |
|
Times cited : (7)
|
|
References (0)
|
